Amgen Wins U.S. Patent Battle on Arthritis Drug Enbrel
Clinical Guidelines for Sjögren’s Syndrome Focus on Biologics, Fatigue, Inflammatory Musculoskeletal Pain
The Birth and Growth of Biotechnology, and the Impact of Biologic Drugs on Rheumatology
Biosimilars to Raise Unique Questions
New Test Yields Rapid Infliximab Drug Concentrations
Update on Legislation, Notification Rules Concerning the Substitution of Interchangeable Biologic Drugs
Understanding Prescription Pathways for Biologic Medication Therapy
Rheumatology Drug Updates: Infliximab Biosimilar Cross Reacts to Infliximab Antibodies
